https://www.reedland.com/wp-content/uploads/2017/04/NeoRx.jpg292560reedlandhttps://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.pngreedland2004-02-23 12:42:462017-04-26 13:03:43NeoRx Completes $9.7 Million Common Stock Financing
https://www.reedland.com/wp-content/uploads/2017/04/Reliant-Pharmaceuticals.jpg292560reedlandhttps://www.reedland.com/wp-content/uploads/2017/05/Reedland-Capital-Partners-Logo.pngreedland2003-09-30 13:45:142017-04-26 13:49:18Reliant Pharmaceuticals Announces $115 Million Initial Closing of Series D Convertible Preferred Units
